Webinars >>Social Media and Clinical Trials
Social Media and Clinical Trials: Patient-Physician Interactions, Patient-Patient Interactions

Social media is a great tool that enables companies to highlight specific issues, addressing concerns, educating patients and doctors alike, and engaging multiple other groups such as patient support groups, families, public policy makers, politicians, and general public. Social media can be used to create awareness about a given trial, disease, patients, and developers. Social media is increasingly used to provide all information about the products being tested, the scientific background, and in general, educating all stakeholders. It makes it easy, accessible, timely and broadly available.
​
While the use of social media as a recruitment tool is quite well known, the impact of social media goes much beyond recruitment of patients and goes into ongoing discussion between patients and investigators, investigators and sponsors, patients with other patients, and sponsor and patients. This seminar will discuss numerous ways in which social media led patient-patient, patient-investigators, investigator-sponsor, and sponsor-patient interactions and data-mining can be conducted for a better, efficient and productive clinical trial. There are also concerns about maintaining trial integrity, logistical affability, and financial feasibility of using social media in clinical trials. FDA rules and industry best practices will be discussed in light of the technological challenges with using social media in clinical trials.
Areas Covered in the Session:
  • Best practices for using social media for patient-investigator interactions
  • Issues related to patient-patient interactions such as “Patientslikeme”
  • Common ways companies are currently using social media in clinical trials
  • FDA rules for using social media in clinical trials
  • Crowd-sourcing, Wiki-creating, data-mining, and other social media practices for clinical trials
  • Recent trends in FDA enforcement actions involving social media.
Why should you attend:
​
The seminar will discuss the best practices, and do’s and don’ts for using social media in clinical trials. Common issues, misconceptions, perceptions, and possible solutions will be discussed. Issues such as role of online patient communities in creating new information repositories, educational tools, information management, crisis management, public relations, and technological consistency will be discussed. Crowd-sourcing of creation, updating, selection, and management of clinical trial information will be discussed using examples from the presenter’s extensive experience in the field. The seminar will provide tips and suggestions for addressing potential issues related to individual, institutional, and regulatory obstacles to using social media in the current research landscape.
Who will benefit: 
​
The following individuals or disciplines will benefit from attending this Webinar:
  • Clinical project managers
  • Clinical research associates
  • Clinical coordinators
  • Principle investigators
  • Compliance Managers
  • Regulatory Vice Presidents, Directors and Managers
  • Attorneys – In-house or Outside Counsel
  • Senior executives of pharmaceutical and device firms
Date: September 19, 2017
Time: 12 PM ET        
​Duration: 60 Minutes

Speaker
Mukesh Kumar, PhD, RAC, VP (Regulatory Affairs and Quality Assurance), Amarex Clinical Research, USA
​

    For more info, fill the box below. We will contact you within 24 hrs.
For additional information on the workshop agenda and logistics, please call 410-501-5777 or email: info@fdamap.com